Although no statistically significant association between BRD9 expression and tumour stage or survival was found in our study, BRD9 importance must not be overlooked, since the available literature states that expression alterations in other important genes such as CDKN2A also do not correlate with patient prognosis in melanoma [35,36,37,44]; this could be the case of BRD9. Moreover, BRD9 inhibition has been shown to result in decreased cell proliferation, G1-arrest, and apoptosis in rhabdoid tumour cell lines [45] and synovial sarcoma [41]. The gene discussed is BRD9; the disease is melanoma.